Title: Final height of growth hormone‐treated patients with growth hormone deficiency: the North American experience
Abstract:Hintz RL. Final height of growth hormone‐treated patients with growth hormone deficiency: the North American experience. Acta Pædiatr 1999; Suppl 428: 70–1. Stockholm. ISSN 0803–5326 The results of tr...Hintz RL. Final height of growth hormone‐treated patients with growth hormone deficiency: the North American experience. Acta Pædiatr 1999; Suppl 428: 70–1. Stockholm. ISSN 0803–5326 The results of treatment of growth hormone (GH)‐deficient patients with recombinant GH are better than the results of treatment with pituitary GH. The reasons for this improvement include higher dosages, more consistent treatment, and daily administration. Under ideal circumstances, final height in patients with GH deficiency (GHD) can be within the normal range for adult height with GH treatment, and brought close to their target height. To achieve this result, it is important to diagnose and treat GHD early, use adequate doses of GH, and continue treatment until final height. □ Growth hormone, growth hormone deficiency, final heightRead More
Publication Year: 1999
Publication Date: 1999-02-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 14
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot